Search Results
Found 1 results
510(k) Data Aggregation
(105 days)
MEDEASY, UNIVERSAL DUO, VELOX, VELOX 2, UNIVERSAL PLUS, UNIVERSAL, LUX, LUX 2, FACILE, CAESAR biopsy needle is intended for use in obtaining biopsies from soft tissues such as liver, kidney, prostate, breast, spleen, lymph nodes and various soft tissue masses. It is not intended for use in bone biopsy
NEO OXUS, HEMAX biopsy needle must be used for bone marrow aspiration and the posterior iliac crest biopsy
PERFECTUS, HANDLEX biopsy needle must be used for bone marrow aspiration from sternum or litac crest
HEPAX biopsy needle is intended for use in obtaining histological biopsies of soft tissues. It is not intended for use in bone biopsy.
FNA (Chiba(Quincke/Turner/Westcott/Fransen) biopsy needles is intended for use in obtaining biopsies from soft tissues such as thyroid, liver, breast, spleen, abdomen, pancreas, lungs, lymph nodes and various soft tissue masses. It is not intended for use in bone biopsy.
Not Found
I am sorry, but the provided text from the FDA 510(k) clearance letter for the Medax Biopsy Systems III does not contain any information about acceptance criteria or a study proving the device meets those criteria, specifically concerning AI/algorithm performance.
The document is a standard 510(k) clearance letter, which focuses on:
- Substantial equivalence to legally marketed predicate devices.
- Regulatory classifications and general controls.
- Indications for Use of the biopsy needles (e.g., for soft tissues, bone marrow aspiration).
Therefore, I cannot extract the information requested for point 1 through 9. The text simply confirms the clearance of medical biopsy devices and their intended uses, not a study involving AI or algorithm performance metrics.
Ask a specific question about this device
Page 1 of 1